CDMO

Vetter wins Axia Best Managed Companies Award

Seal of quality for outstanding corporate management Analysis of the areas of strategy, innovation, corporate culture and finance Comprehensive three-stage…

4 years ago

Dyadic Announces Nonexclusive Research License with WuXi Biologics

New Delhi, March 30, 2020: Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving…

5 years ago

Piramal’s Pharma business grows over 10 % to 4,786 Crore in FY19

 The margins have improved from 10% in FY2011 to 23% in FY2019 Growth is attributed to revenues derived from niche…

5 years ago

Piramal Pharma Solutions Invests $10 million USD to Expand its High Potency API Capability in its Riverview Facility in U.S.

~ Expansion enhances the company’s ability to serve the growing ADC market ~  Michigan, June 21, 2019: Piramal Pharma Solutions (PPS),…

5 years ago

WuXi STA forms Strategic Partnership with Beta Pharma

STA will accelerate process R&D and manufacturing of late phase and commercial targets New Delhi, March 25, 2019: STA Pharmaceutical…

6 years ago

WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery

New Delhi, February 21, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec – and BioLingus, a Swiss…

6 years ago

SIRIO Pharma receives Sports Nutrition Production License approval, potentially opening up sizable sports product growth in China

Shanghai, February 19, 2019: Sirio Pharma Co. Ltd (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – today announces that…

6 years ago

Piramal Pharma Solutions Unveils its New cGMP Kilo Lab Suite for Active Pharmaceutical Ingredient (API) at Ennore, Chennai

Chennai, November 22, 2018: Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO) announced the completion of…

6 years ago

WuXi STA first CDMO to support the approval of an innovative drug in China through the “MAH” pilot

WuXi STA enables Ascletis to receive NDA Approval from China FDA for Ganovo® Shanghai, June 15, 2018: STA Pharmaceutical Co., Ltd. (WuXi…

6 years ago

WuXi STA Changzhou Site Passes First U.S. FDA Inspection

The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval Shanghai, May 11,…

7 years ago